Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Value-Based Contracting: CMS Final Rule Leaves ‘Multiple Best Price’ Questions Unresolved
Jan 05 2021
•
By
Cathy Kelly
CMS To Address 'Multiple Best Price' Questions With Operational Guidance In 2021
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet